1. Introduction {#sec1-molecules-23-01840}
===============

Improvement in the daily nutritional supply and the living environment resulted in the prolongation of our life span, but necessarily increased the number of elderly populations having cognitive diseases \[[@B1-molecules-23-01840],[@B2-molecules-23-01840],[@B3-molecules-23-01840]\]. Alzheimer's disease, the most common form of dementia, is characterized by the accumulation of amyloid-β (Aβ) in the brain. Since the neurotoxicity of Aβ has been well established \[[@B4-molecules-23-01840],[@B5-molecules-23-01840]\], preventing the accumulation \[[@B6-molecules-23-01840]\] and early oligomerization \[[@B7-molecules-23-01840]\] of Aβ may be a promising cognitive behavioral therapy.

Platinum drugs such as cisplatin, carboplatin and oxaliplatin have been important parts of combination chemotherapy regimens to treat different types of solid tumors, but they can cause serious neurotoxicity in the dorsal root ganglion by the formation of adducts to DNA \[[@B8-molecules-23-01840]\]. Taxanes, such as paclitaxel and docetaxel, induce microtubule assembly, mitotic arrest, and finally apoptosis in cancer cells. However, they often induce painful peripheral neurotoxicity during treatment \[[@B9-molecules-23-01840]\]. Patients who received both platinum and taxane treatment showed aggravated neuropathy \[[@B10-molecules-23-01840]\].

Polyphenols---defined as substances that possess an aromatic ring bearing one or more hydroxyl substituents---have been reported to show neuroprotective activity. Polyphenols are roughly classified into the following three groups: Tannins; flavonoids; and, lignin-carbohydrate complexes (LCC) \[[@B11-molecules-23-01840]\]. Tannins are classified into two large groups: Hydrolysable tannins (in which a polyalcohol is esterified with a polyphenolic carboxylic acid such as a galloyl, hexahydroxydiphenoyl, valoneoyl, or dehydrohexahydroxydiphenoyl group); and, condensed tannins (composed of flavan units, mostly catechin, epicatechin, or their analogs, condensed with each other via carbon--carbon bonds) \[[@B12-molecules-23-01840]\]. Flavonoids are secondary metabolites synthesized from chalcones \[[@B13-molecules-23-01840]\] and are categorized into flavonols, flavones, flavanones, isoflavones, pterocarpan and coumestan. Resveratrol is classified as a stilbenoid. Lignins are formed through phenolic oxidative coupling processes. Lignin macromolecules are formed by the dehydrogenative polymerization of three monolignols: *p*-coumaryl, *p*-conifery, and sinapyl alcohols. Some polysaccharides in the cell walls of lignified plants are linked to lignin, and recover as lignin-carbohydrate complex---after extraction with alkaline solution \[[@B14-molecules-23-01840]\].

Previous studies have mostly used low-molecular-weight polyphenols, such as flavonoids and tannins, which manifest various health-promoting activities (antioxidant, anti-inflammatory, and antibacterial activity). This was due to the recent development of separation technology for elucidating their chemical structure \[[@B15-molecules-23-01840],[@B16-molecules-23-01840]\]. On the other hand, the search for neuroprotective, high-molecular substances, such as lignin-carbohydrate complex, have been delayed due to their amorphous structures. They did, however, show prominent anti-HIV activity \[[@B17-molecules-23-01840]\].

Most previous studies of neuroprotection have used rat pheochromocytoma 12 (PC12) \[[@B18-molecules-23-01840]\] and human SH-SY5Y neuroblastoma cell lines \[[@B19-molecules-23-01840],[@B20-molecules-23-01840]\], since these cell lines differentiate into neuronal cells with elongated neurites upon treatment with nerve growth factor (NGF) or retinoic acid.

However, there was no uniformity in the culture condition of PC12 and SH-SY5Y cells in previous investigations. The culture media used was: Dulbecco's modified Eagle's medium (DMEM); the minimum essential medium (MEM); RPMI1640; a mixture of DMEM and Ham′s F12 (1:1); and, non-essential amino acids (NEAA), which were supplemented with fetal bovine serum (FBS), alone or together with, horse serum (HS) (column A in [Table 1](#molecules-23-01840-t001){ref-type="table"}) \[[@B21-molecules-23-01840],[@B22-molecules-23-01840],[@B23-molecules-23-01840],[@B24-molecules-23-01840],[@B25-molecules-23-01840],[@B26-molecules-23-01840],[@B27-molecules-23-01840],[@B28-molecules-23-01840],[@B29-molecules-23-01840],[@B30-molecules-23-01840],[@B31-molecules-23-01840]\]. Differentiated and undifferentiated cells (column B), inoculated at different cell densities, were exposed to considerably different concentrations of neurotoxic agents (column C) in uncoated, collagen, or poly-lysine-coated plates ([Table 1](#molecules-23-01840-t001){ref-type="table"}). Most importantly, previous investigators have not presented the chemotherapeutic index (safety margin). Therefore, it was difficult to compare with previous data on the neuroprotective activity of polyphenols.

In order to investigate the interaction between neuroprotective substances and cells, it is best to use the medium that has the simplest components. We have recently reported that the addition of Ham's F-12 and non-essential amino acids did not increase, but rather, reduced the growth and amino acid consumption of both PC12 and SH-SY5Y cells \[[@B32-molecules-23-01840]\]. During neuronal differentiation induced by NGF, a medium change (that removes numerous neurotrophic factors released from differentiating cells) at an early stage resulted in the poor attachment and low recovery of differentiated cells. If a fresh NGF-containing medium was supplemented by an overlay at the middle stage (without a medium change), comparable numbers of differentiated cells could be harvested after six or seven days, regardless of the types of plates, either non-coated or coated with collagen I or IV. To our surprise, due to its toxicity, the use of poly-lysine coated plates significantly reduced the yield of differentiated cells \[[@B33-molecules-23-01840]\]. Based on these results, DMEM, supplemented with NGF, was adopted as a regular differentiation induction medium, which was added to the culture plates that were not coated with collagen I, IV, or poly-lysine.

Using PC12 cells prepared by the overlay method, we have re-investigated the neuroprotective activity of various polyphenols. This was compared with that of plant extracts and antioxidants, based on the specific index (SI) (defined as the ratio of 50% cytotoxic concentration (CC~50~) to 50% protective concentration (EC~50~)).

2. Results {#sec2-molecules-23-01840}
==========

2.1. Optimal Concentration of Ngf and Fbs for the Induction of PC12 Cell Differentiation {#sec2dot1-molecules-23-01840}
----------------------------------------------------------------------------------------

We first confirmed that NGF stimulated the growth of PC12 cells at the optimal concentration of 50 ng/mL in our assay system. The cell number increased up to day five, and thereafter, slightly declined, possibly due to it reaching the terminal differentiation ([Figure 1](#molecules-23-01840-f001){ref-type="fig"}A). NGF also stimulated the formation of neurite---the marker of neuronal differentiation. When differentiated cells were defined as the cells in which the extended neurite exceeds the longest diameter of each cell ([Figure 1](#molecules-23-01840-f001){ref-type="fig"}B), the percentage of differentiated cells reached a plateau at day five, with a maximum of 50 ng/mL NGF ([Figure 1](#molecules-23-01840-f001){ref-type="fig"}C).

2.2. FBS Inhibited the Differentiation of PC12 Cells {#sec2dot2-molecules-23-01840}
----------------------------------------------------

When PC12 cells were cultured in a serum-free medium, neuronal differentiation reached a maximum level. When inoculation of cell density was reduced to 3.125 × 10^3^/cm^2^, the incidence of cell death slightly increased ([Figure 2](#molecules-23-01840-f002){ref-type="fig"}), which suggests the importance of continuous nutritional supply from neighboring cells. It was unexpected that the maximum differentiation can be achieved in the absence of FBS, and the addition of 1% or 10% FBS inhibited the differentiation induction. Thus, the optimal inoculation of cell density was determined to be between 6 and 12 × 10^3^/cm^2^ in the absence of serum.

2.3. Exploration of the Overlay Method {#sec2dot3-molecules-23-01840}
--------------------------------------

Based on this experimental data, we explored the overlay method to isolate differentiating PC12 cells. PC12 cells were incubated for a total of six or seven days in serum-free DMEM, containing 50 ng/mL NGF, with one more time overlay of NGF ([Figure 3](#molecules-23-01840-f003){ref-type="fig"}). The differentiated cells were well attached to the plate and were not detached by gentle pipetting.

2.4. Apoptosis-Inducing Activity of Neurotoxic Agents {#sec2dot4-molecules-23-01840}
-----------------------------------------------------

We have previously reported that cisplatin showed potent cytotoxicity against differentiated PC12 cells \[[@B34-molecules-23-01840]\], while taxanes (paclitaxel, docetaxel) and amyloid peptides (Aβ~1--42~, Aβ~25--35~) showed cytostatic effects \[[@B34-molecules-23-01840],[@B35-molecules-23-01840]\]. A cell sorter analysis demonstrated that cisplatin induced the apoptosis, characterized by the accumulation of the subG~1~ population ([Figure 4](#molecules-23-01840-f004){ref-type="fig"}). On the other hand, paclitaxel, Aβ~1--42~ and Aβ~25--35~ reduced the population of S-phase cells---reflecting their cytostatic growth inhibition---and accumulated the G2 + M phase cells, in accordance with the reported mitotic arrest by taxanes \[[@B36-molecules-23-01840],[@B37-molecules-23-01840]\]. It was unexpected that differentiated cells were resistant to actinomycin D---a popular apoptosis inducer for various cancer cell lines.

2.5. Neuroprotective Effects of Polyphenols {#sec2dot5-molecules-23-01840}
-------------------------------------------

Alkaline extract from the leaves of *Sasa senanensis* Rehder (SE) protected the cytotoxicity induced by paclitaxel and Aβ~25--35~, but not the cytotoxicity induced by cisplatin. Epigallocatechin gallate (EGCG) and curcumin showed some protective activity when induced by Aβ~25--35~ ([Figure 5](#molecules-23-01840-f005){ref-type="fig"}A).

[Table 2](#molecules-23-01840-t002){ref-type="table"} shows the SI (=CC~50~/EC~50~) value of polyphenols, plant extracts and antioxidants, calculated using the data from our original papers \[[@B33-molecules-23-01840],[@B35-molecules-23-01840],[@B38-molecules-23-01840],[@B39-molecules-23-01840]\] and the present study ([Table 2](#molecules-23-01840-t002){ref-type="table"}). The higher the SI value, the stronger the neuroprotective activity would be expected.

### 2.5.1. Neuroprotective Activity against Undifferentiated PC12 and SH-SY5Y Cells (Exp. 1) {#sec2dot5dot1-molecules-23-01840}

The SE showed the highest neuroprotective activity (SI = 37.2, 141.4, \>108, \<1, \<1, 7.1, 5.9, 5.4), followed by EGCG (SI = 6.1, \<1, \<1, \<1). However, resveratrol (SI = \<1, \>\<1, \<1, \<1), curcumin (SI = \<1, \<1, \<1, \<1) and *p*-coumaric acid (SI = \>\<1, \>\<1, \>\<1, \>\<1) showed no apparent neuroprotective activity \[[@B33-molecules-23-01840]\].

### 2.5.2. Protective Activity against Differentiated PC12 Cells (Exp. 2) {#sec2dot5dot2-molecules-23-01840}

SE showed the highest neuroprotective activity (SI = 45.8, 73.3, 40.2, 7.7, \<1), followed by EGCG (SI = 10.7, 15.1, \<1), and curcumin (SI = 17.3, \<1). Resveratrol did not show any apparent protective activity (SI \< 1). None of these substances were protective against cisplatin-induced neurotoxicity.

### 2.5.3. Neuroprotective Activity of Plant Extracts (Exp. 3) {#sec2dot5dot3-molecules-23-01840}

*Angelica shikokiana* Makino extract \[[@B38-molecules-23-01840]\] and the hot water extract of Miso---a traditional Japanese fermented food that has supported our diet for many years \[[@B39-molecules-23-01840]\]---showed neuroprotective effects against paclitaxel and amyloid peptides ([Figure 5](#molecules-23-01840-f005){ref-type="fig"}B). Especially, a significant (*p* \< 0.05) growth stimulation effect of Miso on Aβ~1--42~ and Aβ~25--35~-treated cells was observed above 0.04%.

2.6. Growth Stimulation by SE {#sec2dot6-molecules-23-01840}
-----------------------------

There was a possibility that neuroprotective effects may be related to the growth stimulation against PC12 cells. To test this possibility, PC12 cells were cultured for 24 h in a serum-free medium containing various sample concentrations. The removal of serum from the cultured medium reduced the growth potential of PC12 cells to 10% of the control level ([Figure 6](#molecules-23-01840-f006){ref-type="fig"}). By the addition of SE, the viability returned back to 40% of the control level, whereas the growth stimulation effects of EGCG, resveratrol, and curcumin was much less ([Figure 6](#molecules-23-01840-f006){ref-type="fig"}).

3. Discussion {#sec3-molecules-23-01840}
=============

We have explored a new and simple method that enabled us to prepare differentiated neuronal cells by the repeated overlay of the NGF-containing medium without a medium change, omitting the use of expensive collagen-coated plates, or the toxic coating step. Using the overlay method, we re-investigated the neuroprotective activity of polyphenols.

SE, a group of three over-the-counter drugs, showed the highest neuroprotective activity against both undifferentiated and differentiated PC12 cells, as well as undifferentiated SH-SY5Y cells. This seems to be linked to growth stimulation at lower doses, known as hormesis \[[@B40-molecules-23-01840]\], since we have experienced similar growth stimulation of SE towards human gingival epithelial fibroblast (HGEP) \[[@B41-molecules-23-01840]\] and PC12 cells \[[@B33-molecules-23-01840]\]. SE showed prominent anti-HIV \[[@B42-molecules-23-01840]\] and anti-UV activity \[[@B43-molecules-23-01840]\], like the lignin-carbohydrate complexes extracted with alkaline solution. The present study further adds that SE showed potent neuroprotective activity. SE contains the lignin-carbohydrate complex and the various degradation products, and thus not a purified material. The lignin-carbohydrate complex showed poor bioavailability \[[@B44-molecules-23-01840]\], and its biological activity might be mediated through one of the pattern-recognition receptors (dectin-2) in the mucosa of oral cavities \[[@B45-molecules-23-01840]\] and intestinal duct. We found that *p*-coumaric acid, one of the lignin precursors present in SE (unpublished data), has no neuroprotective activity. Further fractionation of SE is necessary to identify the neuroprotective substances present in SE.

EGCG, a main component of green tea, showed some neuroprotective activity. We found that higher concentrations of EGCG led to false-positive coloring with MTT reagent---indicated by the red circle in [Figure 5](#molecules-23-01840-f005){ref-type="fig"} and [Figure 6](#molecules-23-01840-f006){ref-type="fig"}---and were possibly due to the non-specific binding of tannin to protein \[[@B46-molecules-23-01840],[@B47-molecules-23-01840]\]. Neuroprotective effects of EGCG may be mediated through cell-surface receptors \[[@B48-molecules-23-01840]\] or by the direct binding to neurotoxic agents.

Curcumin showed some neuroprotective activity against differentiated PC12 cells, but not against undifferentiated cells. The fluctuation in the SI value of this compound may be due to its potent cytotoxicity, narrowing the chemotherapeutic range.

Food polyphenols, at low and nontoxic concentrations, slow down the progression of neurodegenerative diseases and therefore may be a promising approach \[[@B49-molecules-23-01840]\]. It was unexpected that Miso extract also showed neuroprotective ([Figure 5](#molecules-23-01840-f005){ref-type="fig"}B) and growth promotion activity \[[@B38-molecules-23-01840]\], further substantiating the possible link between neuroprotective activity and hormesis. Since Miso is a daily food, it is very much meaningful to identify the active principle for the future research aiming at alleviating the neuronal diseases.

As a mechanism of neuronal protection, activation of the NF-E2 related factor 2 (Nrf2) pathway and the consequent upregulation of detoxification enzymes, such as heme-oxygenase-1 (HO-1), have been suggested \[[@B50-molecules-23-01840],[@B51-molecules-23-01840]\]. However, we have recently reported that the neuroprotective activity of four antioxidants: Docosahexaenoic acid; acetyl-[l]{.smallcaps}-carnitine hydrochloride; *N*-acetyl-[l]{.smallcaps}-cysteine; and, sodium ascorbate, only partially protected PC12 cells from paclitaxel-induced toxicity \[[@B35-molecules-23-01840]\]. Furthermore, it has recently been reported that neuronal protection caused by blackberry polyphenols is produced by mechanisms other than modulating reactive oxygen species (ROS) levels \[[@B52-molecules-23-01840]\]. It is possible that both oxidative and other mechanisms, such as: Autophagy \[[@B21-molecules-23-01840]\]; heat shock protein (HSP)-70 \[[@B22-molecules-23-01840]\]; JAK2/STAT5/Bcl-xL \[[@B24-molecules-23-01840]\]; phosphor HSP-20 \[[@B28-molecules-23-01840]\]; amyloid disaggregation \[[@B29-molecules-23-01840]\]; and, the overexpression of the *KiSS* gene \[[@B30-molecules-23-01840]\], may be involved in the induction of neurotoxicity (column D in [Table 1](#molecules-23-01840-t001){ref-type="table"}).

We have recently manufactured highly tumor-specific derivatives from the chromone core structure found in flavones, isoflavones and 2-styrylchromones, and discovered that their tumor-specificity was correlated with molecular shape and hydrophobicity \[[@B53-molecules-23-01840],[@B54-molecules-23-01840]\]. By analogy, for searching new neuroprotective substances, it may be one way to introduce various functional groups to the core substance present in the natural kingdom, repeat the synthesis, and verify the process using QSAR analysis.

4. Materials and Methods {#sec4-molecules-23-01840}
========================

4.1. Materials {#sec4dot1-molecules-23-01840}
--------------

The following chemicals and reagents were obtained from the indicated companies: DMEM; human recombinant NGF; paclitaxel; propidium iodide (PI); actinomycin D (Act. D); 4% paraformaldehyde phosphate buffer solution; dimethyl sulfoxide (DMSO) (Wako Pure Chemical Ind., Ltd., Osaka, Japan); Nonidet P-40 (NP-40) (Nakalai Tesque Inc., Kyoto, Japan); FBS; 3-(4,5-dimethylthiazol-2-yl)-2; 5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich Inc., St. Louis, MO, USA); Aβ~1--42~ and Aβ~25--35~ (Cosmo Bio Co., Ltd., Tokyo, Japan); NGF (dissolved in water at 0.5 mg/mL); Aβ~1--42~ (dissolved in DMSO at 1 mM); and, Aβ~25--35~ (dissolved in water at 0.1 mM) were frozen at −20 °C. The following 96-microwell plates were purchased from TPP (Techno Plastic Products AG, Trasadingen, Switzerland).

4.2. Cell Culture {#sec4dot2-molecules-23-01840}
-----------------

PC12 cells were purchased from Riken Cell Bank (Tsukuba, Japan). These cells were cultured in DMEM and were supplemented with 10% FBS, 100 units/mL, penicillin G and 100 µg/mL streptomycin under a humidified 5% CO~2~ atmosphere.

4.3. Determination of Viable Cell Numbers {#sec4dot3-molecules-23-01840}
-----------------------------------------

To the culture medium, a fresh medium containing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (final concentration: 0.1 mg/mL) with (for differentiated cells) or without (for non-differentiated cells) of 50 ng/mL NGF. The cells were incubated for 1 h, and the formazan precipitate was dissolved in DMSO to measure their absorbance at 560 nm with a plate reader (Infinite F 50 R, TECAN, Kawasaki, Japan).

4.4. Induction of Differentiation Toward Neurons {#sec4dot4-molecules-23-01840}
------------------------------------------------

For the induction of differentiation, PC12 cells were incubated for the indicated times with a differentiating inducing medium (DMEM, supplemented with 0% or 1% FBS, 50 ng/mL NGF and antibiotics). Differentiated cells were defined as the cells in which the extended neuritis exceeded the longest diameter of each cell, assessed under the light microscope (EVOS FL, ThermoFisher Scientific, Waltham, MA, USA) ([Figure 1](#molecules-23-01840-f001){ref-type="fig"}B).

4.5. Neuroprotection Assay {#sec4dot5-molecules-23-01840}
--------------------------

Undifferentiated (PC12, SH-SY5Y) and differentiated PC12 cells were pretreated for 1 h with test samples, and then neurotoxic agents were added (0.3 μM, Aβ~1--42~, 2 μM Aβ~25--35~, 50 μM cisplatin, 0.4 μM paclitaxel). After treatment for 24 or 48 h, viable cell numbers were determined, as described above. The 50% cytotoxic concentration (CC~50~) was determined from the neurotoxicant-free culture, and the 50% effective concentration (EC~50~) that reduced the neurotoxicant-induced cytotoxicity by 50% was calculated ([Figure 5](#molecules-23-01840-f005){ref-type="fig"}). The protective effect was quantified by the SI, using the following formula: SI = CC~50~/EC~50~ ([Figure 5](#molecules-23-01840-f005){ref-type="fig"}).

4.6. Cell Cycle Analysis {#sec4dot6-molecules-23-01840}
------------------------

Cells (approximately 10^6^) were harvested, fixed with a 1% paraformaldehyde in phosphate-buffered saline without calcium or magnesium ions \[PBS(−)\]. Fixed cells were washed twice with PBS(−), and then treated for 30 min with 400 μL of 0.2 mg/mL RNase A (preheated for 10 min at 100 °C to deactivate DNase) to degrade RNA. Cells were then washed twice with PBS(−) and stained for 15 min with 0.005% propidium iodide (PI) in the presence of 0.01% NP-40 in PBS(−), which prevents cell aggregation. After filtering through Falcon^®^ cell strainers (40 μM) (Corning Inc., Corning, NY, USA) to remove aggregated cells, PI-stained cells were subjected to a cell sorter (SH800 Series, SONY Imaging Products and Solutions Inc., Kanagawa, Japan). Cell cycle analysis was performed with the Cell Sorter Software version 2.1.2 (SONY Imaging Products and Solution Inc., Kanagawa, Japan).

4.7. Statistical Treatment {#sec4dot7-molecules-23-01840}
--------------------------

Experimental values are expressed as the mean ± standard deviation (SD) of triplicate or quadruplicate samples. Statistical analysis was performed using Student's *t*-test. A *p*-value of \<0.05 was considered to be significant.

5. Conclusions {#sec5-molecules-23-01840}
==============

The present study demonstrated that plant extracts, having hormetic growth stimulation, showed higher neuroprotective activity than lower molecular weight polyphenols. The overlay method, that can prepare massive differentiated neuronal cells, may be applicable for the study of differentiation-associated changes in intracellular metabolites by metabolomics, and the interaction between neuronal cells and physiological factors.
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![Stimulation of the growth and differentiation of PC12 cells by NGF. Cells were inoculated at 2 × 10^3^/96-microwell plate (6.25 × 10^4^/cm^2^). After 24 h, the medium was replaced with a serum-free medium containing the indicated concentrations of NGF. At day three, additional NGF was supplemented on top of the medium. Viable cell number (**A**), and the percentage of differentiated cells, defined as in (**B**), and undifferentiated cells (counted after subtraction of differentiated cells and dead cells) (**C**), was then determined. In (**B**), (a) is the longest diameter of the cells, and (b) is the length of extended neurites. Each value represents the mean ± S.D. of 6 determinations.](molecules-23-01840-g001){#molecules-23-01840-f001}

![FBS reduced the neuronal differentiation of PC12 cells. PC12 cells were seeded at 3.125, 6.25 and 12.5 × 10^3^/cm^2^ into a 96-microwell plate. After 24 h, cells were replaced with DMEM supplemented with 0%, 1% or 10% FBS containing 50 ng/mL NGF, and were incubated for zero, four or seven days, with a one-time supplementation of NGF overlay at day three. The percentage of differentiated cells and undifferentiated cells (defined in the legend of [Figure 1](#molecules-23-01840-f001){ref-type="fig"}) (**A**), viable cell number (**B**) and morphological changes were monitored. To score the number of differentiated cells, the morphology of more than 100 cells were observed under the light microscope.](molecules-23-01840-g002){#molecules-23-01840-f002}

![Schematic diagram of overlay method.](molecules-23-01840-g003){#molecules-23-01840-f003}

![Cell cycle analysis of differentiated PC12 cells (day three) after treatment with neurotoxic agents. Each value represents the mean ± S.D. of triplicate assays.](molecules-23-01840-g004){#molecules-23-01840-f004}

![Neuroprotective effects of various polyphenols and plant extracts. Concentration of neurotoxic agents are: Aβ~25--35~ (500 nM); cisplatin (50 μM); and, paclitaxel (50 nM).](molecules-23-01840-g005){#molecules-23-01840-f005}

![Growth stimulation activity of various polyphenols. PC12 cells were cultured for 24 h in DMEM, supplemented with 10% FBS (indicated by C (control) in blue), or without serum (red) in the presence of indicated concentrations of test samples. The viable cell number was then measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reagent, and expressed as a percentage of control (C). Each value represents the mean ± S.D. of six determinants.](molecules-23-01840-g006){#molecules-23-01840-f006}

molecules-23-01840-t001_Table 1

###### 

Culture system for PC12 cells used by previous researchers.

  Cell      Culture Medium                            Differentiation-Induction Medium                                                Cytotoxicity Induced by   Rescue System            Ref
  --------- ----------------------------------------- ------------------------------------------------------------------------------- ------------------------- ------------------------ -------------------------------
  PC12      RPMI1640 + 10%FBS + 5%HS                  NGF (50 ng/mL) in serum-free RPMI1640 for 7 days                                Aβ~25--35~ (5--10 μM)     Autophagy                \[[@B21-molecules-23-01840]\]
  PC12      RPMI1640 + 10%FBS + 5%HS                  NGF (25 ng/mL) in RPMI1640 + 10%FBS + 5%HS in collagen-coated dish for 2 days   Aβ~25--35~ (10 μM)        HSP-70                   \[[@B22-molecules-23-01840]\]
  PC12      RPMI1640 + 5%FBS + 10%HS                  No treatment                                                                    Aβ~1--42~ (75 μM)         ROS reduction            \[[@B23-molecules-23-01840]\]
  PC12      DMEM + 10%FBS                             No treatment                                                                    Aβ~25--35~ (20 μM)        JAK2/STAT5/Bcl-xL        \[[@B24-molecules-23-01840]\]
  PC12      DMEM + 10%FBS                             No treatment                                                                    Aβ~25--35~ (20 μM)                                 \[[@B25-molecules-23-01840]\]
  SH-SY5Y   DMEM + 10%FBS                             No treatment                                                                    Aβ~1--42~ (0.5 μM)        HO-1 CO                  \[[@B26-molecules-23-01840]\]
  SH-SY5Y   DMEM/Ham's F-12 (1:1) + 10%FBS            All-trans-retinoic acid (10 μM) + 3%FBS for 7--8 days                           Aβ~25--35~ (20 μM)                                 \[[@B27-molecules-23-01840]\]
  SH-SY5Y   DMEM/Ham's F-12 (1:1) + 10%FBS            No treatment                                                                    Aβ~1--42~ (1--50 μM)      Phospho HSP-20           \[[@B28-molecules-23-01840]\]
  SH-SY5Y   MEM/Ham's F-12 (1:1) + 10%FBS             No treatment                                                                    Aβ~1--42~ (20 μM)         Amyloid disaggregation   \[[@B29-molecules-23-01840]\]
  SH-SY5Y   DMEM/Ham's F-12 (1:1) + 10%FBS + 1%NEAA   No treatment                                                                    Aβ~1--40~ (10 μM)         KiSS overexpression      \[[@B30-molecules-23-01840]\]
  PC12      DMEM/Ham's F-12 (1:1) + 5%FBS + 10%HS     NGF (25 ng/mL) in RPMI1640 + 10%FBS + 5%HS in collagen-coated dish                                                                 \[[@B31-molecules-23-01840]\]

FBS, fetal bovine serum; HS, horse serum; NEAA, non-essential amino acids.

molecules-23-01840-t002_Table 2

###### 

Neuroprotective activity of polyphenols and plant extracts.

           Target Cell                                FBS   Toxicant     Protective Substance                            CC~50~   EC~50~   SI       Ref              
  -------- ---------------------------------- ------- ----- ------------ ----------------------------------------------- -------- -------- -------- ------- -------- -------------------------------
  Exp. 1   \<Undifferentiated cell system\>                                                                                                                          
           SH-SY5Y                            Day 0   10%   Aβ~1--42~    SE                                              4.19     \%       0.11     \%      37.2     \[[@B33-molecules-23-01840]\]
                                                            Aβ~1--42~    SE                                              2.22     \%       0.016    \%      141.4    \[[@B33-molecules-23-01840]\]
                                                            Aβ~1--42~    EGCG                                            66       μM       \>400    μM      6.1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~1--42~    Resveratrol                                     387      μM       \>400    μM      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~1--42~    Curcumin                                        46       μM       \>200    μM      \<1      
                                                            Aβ~1--42~    *p*-Coumaric acid                               \>400    μM       \>400    μM      \>\<1    
                                                      10%   Aβ~25-35~    SE                                              2.69     \%       \<0.21   \%      \>108    \[[@B33-molecules-23-01840]\]
                                                            Aβ~25--35~   SE                                              2.22     \%       \>3.13   \%      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~25--35~   EGCG                                            47.8     μM       \>400    μM      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~25-35~    Resveratrol                                     \>400    μM       \>400    μM      \>\<1    \[[@B33-molecules-23-01840]\]
                                                            Aβ~25--35~   Curcumin                                        17.4     μM       \>200    μM      \<1      
                                                            Aβ~25--35~   *p*-Coumaric acid                               \>400    μM       \>400    μM      \>\<1    
           PC12                               Day 0   10%   Aβ~1--42~    SE                                              1.38     \%       \>1.56   \%      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~1--42~    SE                                              0.71     \%       0.1      \%      7.1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~1--42~    EGCG                                            40.1     μM       \>400    μM      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~1--42~    Resveratrol                                     326      μM       \>400    μM      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~1-42~     Curcumin                                        19.1     μM       \>200    μM      \<1      
                                                            Aβ~1--42~    *p*-Coumaric acid                               \>400    μM       \>400    μM      \>\<1    
                                                      10%   Aβ~25--35~   SE                                              1.15     \%       0.21     \%      5.9      \[[@B33-molecules-23-01840]\]
                                                            Aβ~25--35~   SE                                              0.71     \%       0.13     \%      5.4      \[[@B33-molecules-23-01840]\]
                                                            Aβ~25--35~   EGCG                                            33.1     μM       \>400    μM      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~25--35~   Resveratrol                                     370      μM       \>400    μM      \<1      \[[@B33-molecules-23-01840]\]
                                                            Aβ~25--35~   Curcumin                                        60.2     μM       \>200    μM      \<1      
                                                            Aβ~25--35~   *p*-Coumaric acid                               \>400    μM       \>400    μM      \>\<1    
  Exp. 2   \<Differentiated cell system\>                                                                                                                            
           PC12                               Day 7   1%    Aβ~1--42~    SE                                              0.55     \%       0.012    \%      45.8     \[[@B33-molecules-23-01840]\]
                                                      1%    Aβ~25--35~   SE                                              0.55     \%       0.0075   \%      73.3     \[[@B33-molecules-23-01840]\]
           PC12                               Day 6   0%    Aβ~25--35~   SE                                              0.2      \%       0.005    \%      40.2     
                                                      0%    Paclitaxel   SE                                              0.2      \%       0.026    \%      7.7      
                                                      0%    Cisplatin    SE                                              0.2      \%       \>2      \%      \<1      
                                                      0%    Aβ~25--35~   EGCG                                            8.33     μM       0.78     μM      10.7     
                                                      0%    Paclitaxel   EGCG                                            8.33     μM       0.55     μM      15.1     
                                                      0%    Cisplatin    EGCG                                            8.33     μM       \>25     μM      \<1      
                                                      0%    Cisplatin    Resveratrol                                     60.4     μM       \>200    μM      \<1      
                                                      0%    Aβ~25--35~   Curcumin                                        15.7     μM       0.91     μM      17.3     
                                                      0%    Cisplatin    Curcumin                                        15.7     μM       \>200    μM      \<1      
  Exp. 3                                                                 \<Plant extracts\>                                                                          
                                                                         *Angelica shikokiana* Makino root                                                           
                                              Day 0   10%   Aβ~1--42~    Leaf PBS extract                                1472     μg/mL    417      μg/mL   3.5      \[[@B38-molecules-23-01840]\]
                                                                         Root PBS extract                                2686     μg/mL    107      μg/mL   25.1     \[[@B38-molecules-23-01840]\]
                                                                         Seed PBS extract                                2118     μg/mL    41.7     μg/mL   50.8     \[[@B38-molecules-23-01840]\]
                                                                         Leaf NaHCO~3~ extract                           1827     μg/mL    4.71     μg/mL   387.9    \[[@B38-molecules-23-01840]\]
                                                                         Root NaHCO~3~ extract                           2691     μg/mL    43.8     μg/mL   61.4     \[[@B38-molecules-23-01840]\]
                                                                         Seed NaHCO~3~ extract                           2441     μg/mL    73.9     μg/mL   33       \[[@B38-molecules-23-01840]\]
                                              Day 6   1%    Paclitaxel   Root PBS extract                                \>2000   μg/mL    107      μg/mL   \>18.7   \[[@B38-molecules-23-01840]\]
                                                                                                                                                                     
                                              Day 6         Aβ~1--42~    Miso extract                                    6.83     \%       0.039    \%      175.1    \[[@B39-molecules-23-01840]\]
                                              Day 6         Aβ~25--35~   Miso extract                                    6.83     \%       0.191    \%      35.8     \[[@B39-molecules-23-01840]\]
  Exp. 4                                                                 \<Antioxidants\>                                                                            
                                              Day 5         Paclitaxel   Docosahexaenoic acid                            0.017             \>0.02           \<1      \[[@B35-molecules-23-01840]\]
                                                                         Acetyl-[l]{.smallcaps}-carnitine hydrochlorid   \>10              0.07             142.9    \[[@B35-molecules-23-01840]\]
                                                                         *N*-Acetyl-[l]{.smallcaps}-cysteine             \>10              2.25             \>4.4    \[[@B35-molecules-23-01840]\]
                                                                         Sodium ascorbate                                0.52              \>1              \<1      \[[@B35-molecules-23-01840]\]
